legal-news

9:20-md-02924 IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION

20-md-02924 Filed
Active Court order issued Sign in to follow this case
Share mail
Advertisement
description

Case Summary

IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION is a multidistrict litigation (MDL) involving claims related to Zantac products. The court granted a motion to withdraw as attorney, indicating changes in legal representation for one or more parties. The MDL consolidates numerous related claims for coordinated pretrial proceedings.

Stage

Court order issued

Timeline

1 event

Coverage

1 article

Sources

1

Key Issues

  • Products liability
  • Multidistrict litigation
  • Attorney withdrawal
  • Pretrial coordination
Advertisement

Case Timeline

1 event
gavel
Order April 13, 2026

9:20-md-02924 IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION

The court issued an order approving a lawyer's request to withdraw from representing a party in the Zantac products liability lawsuit. This means the attorney will no longer be involved in the case, which could affect the legal strategy or timeline. It matters because changes in legal representation can impact how the case proceeds and the parties involved.

Advertisement
newspaper

Press Coverage

1 article